TNFRSF1B and malignant colon neoplasm: In combination therapy, ansofaxine hydrochloride enhanced the efficacy of anti-TNFR2 in colon cancer, enabling eradication of established tumors in 20% of mice, and triggering syngeneic tumor-specific systemic immunity.